Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene
- Molecular classification
- Pseudogene, Long non-coding RNA (lncRNA, some pseudogenes are transcribed and may function as non-coding RNAs)
01
Overview
Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene is a non-functional genomic sequence related to the UBA52 gene, which encodes a ubiquitin-ribosomal protein fusion protein. Pseudogenes do not produce functional proteins but may sometimes be transcribed as non-coding RNAs; their biological roles, if any, are typically regulatory rather than coding. While the functional UBA52 gene is essential for protein homeostasis and ribosome structure, the pseudogene version retains sequence similarity but is not involved in these cellular functions.
- Other names
- UBA52PUbiquitin/52-residue ribosomal protein fusion gene pseudogeneUbA52 pseudogene
02
Biological functions
Other (Pseudogenes often do not encode a protein but may participate in post-transcriptional regulation through non-coding RNA mechanisms such as miRNA decoys or regulatory lncRNA; not confirmed for this pseudogene specifically)
03
Disease associations
Other (Some pseudogenes are implicated in cancer as regulators of coding genes; however, no specific disease role is established for ENSG00000241035)
Beyond the preview
Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene.